You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-STAT3 (phospho S727) antibody [E121-31] (ab32143)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-STAT3 (phospho S727) antibody [E121-31]
See all STAT3 products (27) ...

Description

Rabbit monoclonal [E121-31] to STAT3 (phospho S727)

Specificity

This antibody detects Stat3 phosphorylated on Serine 727. It does not crossreact with the phospho serines of other Stat proteins.

Tested applications

ICC/IF, IP, WBmore details

Cross reactivity

Reacts with

Rat, Human

Predicted to work with

Horse, Cow

Does not react with

Mouse

Immunogen

Synthetic peptide: SNTIDLPMSPPRTLDS, corresponding to amino acids 719-733 of Human STAT3

SNTIDLPMSPPRTLDS

Positive control

WB: A431 cell lysate.

General notes

Produced under U.S. Patent No. 5,675,063.

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.

Storage buffer

PBS 49%,Sodium azide 0.01%,Glycerol 50%,BSA 0.05%

Concentration

Concentration information loading...

Clonality

Monoclonal

Clone number

E121-31

Isotype

IgG

  • Western blot - STAT3 (phospho S727) antibody [E121-31] (ab32143)Western blot - STAT3 (phospho S727) antibody [E121-31] (ab32143) image (enlarge)

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - STAT3 (phospho S727) antibody [E121-31] (ab32143)Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - STAT3 (phospho S727) antibody [E121-31] (ab32143) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab32143 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

ICC/IF: 1/100.
IP: 1/40.
WB: 1/1000 - 1/2000. Detects a band of approximately 98 kDa (predicted molecular weight: 88 kDa).

Is unsuitable for FACS.

Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Function

Transcription factor that binds to the interleukin-6 (IL-6)-responsive elements identified in the promoters of various acute-phase protein genes. Activated by IL31 through IL31RA.

Tissue specificity

Heart, brain, placenta, lung, liver, skeletal muscle, kidney and pancreas.

Involvement in disease

Defects in STAT3 are the cause of hyperimmunoglobulin E recurrent infection syndrome autosomal dominant (AD-HIES) [MIM:147060]; also known as hyper-IgE syndrome or Job syndrome. AD-HIES is a rare disorder of immunity and connective tissue characterized by immunodeficiency, chronic eczema, recurrent Staphylococcal infections, increased serum IgE, eosinophilia, distinctive coarse facial appearance, abnormal dentition, hyperextensibility of the joints, and bone fractures.

Sequence similarities

Belongs to the transcription factor STAT family.
Contains 1 SH2 domain.

Post-translational
modifications

Tyrosine phosphorylated upon stimulation with EGF (By similarity). Tyrosine phosphorylated in response to IL-6, IL-11, CNTF, LIF, CSF-1, EGF, PDGF, IFN-alpha and OSM. Phosphorylated on serine upon DNA damage, probably by ATM or ATR. Serine phosphorylation is important for the formation of stable DNA-binding STAT3 homodimers and maximal transcriptional activity. ARL2BP may participate in keeping the phosphorylated state of STAT3 within the nucleus.

Cellular localization

Cytoplasm. Nucleus. Shuttles between the nucleus and the cytoplasm. Constitutive nuclear presence is independent of tyrosine phosphorylation. Predominantly present in the cytoplasm without stimuli. Upon leukemia inhibitory factor (LIF) stimulation, accumulates in the nucleus. The complex composed of BART and ARL2 plays an important role in the nuclear translocation and retention of STAT3.

Target information above from: UniProt accessionP40763 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • 1110034C02Rik antibody
  • Acute Phase Response Factor antibody
  • Acute-phase response factor antibody
  • APRF antibody
  • AW109958 antibody
  • DNA binding protein APRF antibody
  • FLJ20882 antibody
  • HIES antibody
  • MGC128731 antibody
  • MGC16063 antibody
  • MGC93551 antibody
  • Signal transducer and activator of transcription 3 (acute-phase response factor) antibody
  • Signal transducer and activator of transcription 3 antibody
  • Signal Transductor and Activator of Transcription 3 antibody
  • STAT 3 antibody
  • Stat3 antibody
  • STAT3_HUMAN antibody
  • Transcription factor antibody
see all

Anti-STAT3 (phospho S727) antibody [E121-31] images:

  Western blot - STAT3 (phospho S727) antibody [E121-31] (ab32143)

Western blot - STAT3 (phospho S727) antibody [E121-31] (ab32143)

All lanes : Anti-STAT3 (phospho S727) antibody [E121-31] (ab32143) at 1/1000 dilution

Lane 1 : A431 cell lysate
Lane 2 : A431 + EGF cell lysate


Predicted band size : 88 kDa
Observed band size : 98 kDa (why is the actual band size different from the predicted?)

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - STAT3 (phospho S727) antibody [E121-31] (ab32143)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - STAT3 (phospho S727) antibody [E121-31] (ab32143)

IHC-P analysis of brain astrocytoma using ab32143 at 1/50 dilution.

References for Anti-STAT3 (phospho S727) antibody [E121-31] (ab32143)

ab32143 has not yet been referenced specifically in any publications.

Publishing research using ab32143? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"